Approval · Notice of Compliance 8148 · 2006
APO-METHOTREXATE: Notice of Compliance 8148
Issued July 14, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8148
- Date
- July 14, 2006
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antimetabolite
- Canadian reference product
- METHOTREXATE (Wyeth-Ayerst Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-METHOTREXATE | 02283697 | Approved |
Medicinal ingredients
- METHOTREXATE 2.5 MG per TAB